Entrectinib market price and trend analysis in 2025

As of2025, entrectinib (Entrectinib) has been launched in China and has been successfully included in the medical It is guaranteed to become one of the effective drugs for the treatment of NTRK gene fusion-positive tumors, ALK gene rearrangement-positive non-small cell lung cancer and other cancers. At present, the market price of entrectinib is about 20,000 yuan, but the specific price will fluctuate depending on regions, hospitals and medical insurance policies. When purchasing medicines, patients should consult the local hospital pharmacy or medical insurance department to learn about the specific medical insurance reimbursement prices and personal burdens.

With the popularity of entrectinib in China, drug prices have been relatively stable, but whether prices will increase or change in the future is still affected by a number of factors. For example, drug production costs, supply chain changes, adjustments to medical insurance reimbursement policies, and the emergence of other competing drugs may all cause certain fluctuations in prices. In addition, as patient use increases, some manufacturers may reduce costs through mass production, thus affecting prices.

In foreign markets, the price of entrectinib is relatively cheap. Taking the Lao version of generic drugs as an example, the price of entrectinib generic drugs with specifications of 100mg*60 tablets is about more than 1,000 yuan. This price is much lower than the selling price of the original drug, and the ingredients of the drug are basically the same as the original drug, and it can provide the same efficacy and safety as the original drug. Therefore, some patients choose to reduce the cost of treatment by purchasing generic drugs overseas.

Generally speaking, the price of entrectinib in China is currently relatively high, but the coverage of medical insurance has greatly reduced the financial burden on patients. As more generic drugs are launched and market competition intensifies, it is expected that the price of entrectinib may decline in the future. Especially for some patients with non-urgent treatment, purchasing generic drugs through overseas channels may become an affordable option. However, no matter which route is chosen, patients should pay special attention to the quality and source of the medicine when purchasing to ensure that the medicine they purchase meets safety standards.

Reference materials:https://www.roche.com/products/rozlytrek